Compare ALEMBIC with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs SHASUN PHARMA - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC SHASUN PHARMA ALEMBIC/
SHASUN PHARMA
 
P/E (TTM) x 78.6 123.9 63.5% View Chart
P/BV x 6.8 8.5 79.5% View Chart
Dividend Yield % 0.2 0.2 64.5%  

Financials

 ALEMBIC   SHASUN PHARMA
EQUITY SHARE DATA
    ALEMBIC
Mar-18
SHASUN PHARMA
Mar-14
ALEMBIC/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs7294 76.4%   
Low Rs3446 74.3%   
Sales per share (Unadj.) Rs4.7214.2 2.2%  
Earnings per share (Unadj.) Rs6.15.3 114.4%  
Cash flow per share (Unadj.) Rs6.215.8 39.5%  
Dividends per share (Unadj.) Rs0.201.00 20.0%  
Dividend yield (eoy) %0.41.4 26.4%  
Book value per share (Unadj.) Rs40.753.3 76.2%  
Shares outstanding (eoy) m267.0356.62 471.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.30.3 3,451.6%   
Avg P/E ratio x8.713.1 66.2%  
P/CF ratio (eoy) x8.54.4 191.9%  
Price / Book Value ratio x1.31.3 99.4%  
Dividend payout %3.318.7 17.5%   
Avg Mkt Cap Rs m14,1393,958 357.3%   
No. of employees `000NANA-   
Total wages/salary Rs m2072,164 9.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,25512,127 10.4%  
Other income Rs m370229 161.4%   
Total revenues Rs m1,62512,356 13.2%   
Gross profit Rs m1111,009 11.0%  
Depreciation Rs m38594 6.4%   
Interest Rs m2415 0.4%   
Profit before tax Rs m442230 192.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120 -404,000.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24-73 -32.9%   
Profit after tax Rs m1,630302 539.5%  
Gross profit margin %8.98.3 106.4%  
Effective tax rate %5.4-31.7 -17.1%   
Net profit margin %129.82.5 5,212.0%  
BALANCE SHEET DATA
Current assets Rs m1,8676,884 27.1%   
Current liabilities Rs m5918,456 7.0%   
Net working cap to sales %101.6-13.0 -784.4%  
Current ratio x3.20.8 387.9%  
Inventory Days Days9462 152.9%  
Debtors Days Days74108 68.4%  
Net fixed assets Rs m1,7914,970 36.0%   
Share capital Rs m534113 471.4%   
"Free" reserves Rs m10,3242,875 359.1%   
Net worth Rs m10,8583,020 359.5%   
Long term debt Rs m411,817 2.3%   
Total assets Rs m11,59113,347 86.8%  
Interest coverage x260.91.6 16,794.7%   
Debt to equity ratio x00.6 0.6%  
Sales to assets ratio x0.10.9 11.9%   
Return on assets %14.15.4 262.0%  
Return on equity %15.010.0 150.1%  
Return on capital %15.213.3 114.0%  
Exports to sales %1.546.4 3.3%   
Imports to sales %21.014.2 147.3%   
Exports (fob) Rs m195,622 0.3%   
Imports (cif) Rs m2631,728 15.2%   
Fx inflow Rs m195,843 0.3%   
Fx outflow Rs m2642,173 12.1%   
Net fx Rs m-2443,669 -6.7%   
CASH FLOW
From Operations Rs m236398 59.3%  
From Investments Rs m-224-1,635 13.7%  
From Financial Activity Rs m-271,309 -2.0%  
Net Cashflow Rs m-1571 -20.8%  

Share Holding

Indian Promoters % 64.0 39.2 163.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 3.6 5.6%  
FIIs % 9.7 17.6 55.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 39.6 65.9%  
Shareholders   54,701 20,750 263.6%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   DIVIS LABORATORIES  WOCKHARDT  SUN PHARMA  FRESENIUS KABI ONCO.  FDC  

Compare ALEMBIC With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

SGX Nifty Trades Flat, Interglobe Aviation QIP, Rising Premium for Non-Life Insurers, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended lower yesterday. Benchmark indices ended nearly 1% lower, tracking weakness in global markets and dragged primarily by finance and banking stocks.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


May 11, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS